Tower Research Capital (TRC)’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,076
Closed -$29.3K 5222
2026
Q1
$29.3K Buy
+2,076
New +$30.6K ﹤0.01% 3189
2022
Q1
Sell
-2,271
Closed -$44K 6083
2021
Q4
$44K Buy
+2,271
New +$44.2K ﹤0.01% 2855
2021
Q1
Sell
-200
Closed -$4K 5392
2020
Q4
$4K Buy
+200
New +$4.24K ﹤0.01% 4686

Other funds holding BCAT

Tower Research Capital (TRC)'s BCAT Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026, closing a stake of 2,076 shares — an estimated $29.3K sold.

Tower Research Capital (TRC) first reported a position in BCAT in Q4 2020 and held it in 3 quarters. The position peaked at $44K in Q4 2021. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,076 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $29.3K.
  • Tower Research Capital (TRC) first reported a position in BlackRock Capital Allocation Term Trust in Q4 2020 and held it in 3 quarters.
  • Tower Research Capital (TRC)'s BlackRock Capital Allocation Term Trust position peaked at $44K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.